Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Alfredo Addeo MD

Alfredo Addeo MD

Senior Oncologist, Geneva University Hospital, Geneva, Switzerland

Dr. Alfredo Addeo is an senior oncologist at the Geneva University Hospital, Geneva Switzerland.

He completed his training and received a MD in oncology at the University school  of medicine of Turin (Italy).

Dr. Addeo has been working on Thoracic malignancies since 2006 and he is the lead thoracic oncologist at University Hospital of Geneva. Authors of several publications on international peer-reviewed journal

Disclosures

Dr. Addeo reported receiving personal fees for attending advisory from Bristol‐Myers Squibb, AstraZeneca, Roche, Pfizer, Merck Sharp and Dohme,Astella, Eli Lilly and Boehringer‐Ingelheim. He has received fees for speaking bureau for Eli Lilly, AstraZeneca, MSD for work performed outside of the current study.

Recent Contributions to PracticeUpdate:

  1. Neoadjuvant Durvalumab With or Without Stereotactic Body Radiotherapy in Patients With Early-Stage NSCLC

Recently Updated